Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
3(75.0%)
Phase 4
1(25.0%)
4Total
Phase 2(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT03909217Phase 2Completed

Treating Depression With Transcutaneous Electrical Cranial-auricular Acupoint Stimulation (TECAS).

Role: collaborator

NCT03709849Phase 2Unknown

Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility

Role: collaborator

NCT03704506Phase 4Unknown

Registration of the Study of Reyanning Mixture

Role: collaborator

NCT02583802Phase 2Unknown

The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients

Role: collaborator

All 4 trials loaded